Sales value of drugs used in diabetes in Spain 2007-2021
The sales value of drugs used to treat diabetes in Spain increased by 164.8 million euros (+8.99%) since the previous year. Therefore, the total sales value in Spain reached a peak in 2021 with 2 billion euros. Notably, the total sales value continuously increased over the last years.
Drugs are classified by the ATC code (Anatomical Therapeutic Chemical Classification System). Drugs used in diabetes are classified under ATC code A10. Diabetes drugs can be divided in three major groups: insulins and analogues, blood glucose lowering drugs (excluding insulins), and other drugs used for the treatment of diabetes (aldose reductase inhibitors).
Find more statistics on similiar topics in Spain with key insights such as total value of antiarrhythmics class i and iii pharmaceutical sales and total value of beta blocking agents pharmaceutical sales.
Drugs are classified by the ATC code (Anatomical Therapeutic Chemical Classification System). Drugs used in diabetes are classified under ATC code A10. Diabetes drugs can be divided in three major groups: insulins and analogues, blood glucose lowering drugs (excluding insulins), and other drugs used for the treatment of diabetes (aldose reductase inhibitors).
Find more statistics on similiar topics in Spain with key insights such as total value of antiarrhythmics class i and iii pharmaceutical sales and total value of beta blocking agents pharmaceutical sales.
